The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2020 | Challenges in managing myeloma patients
Meletios Dimopoulos
• 2 Jun 2020
Meletios Dimopoulos, MD, of the Kapodistrian University of Athens School of Medicine, Athens, Greece, discusses some of the challenges facing the management of myeloma patients and highlights the need for novel therapies to myeloma subgroups that have an unmet need. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
